MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Curis, Inc. - Common Stock (NQ:CRIS)

4.980 +0.250 (+5.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Curis, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
46 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67... 
Via Benzinga
Topics Initial Public Offering
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,... 
Via Benzinga
News headline image
Mid-Day Market Update: Markets Mixed; Novan Shares Spike Higher ↗
Midway through trading Friday, the Dow traded down 0.07% to 34,442.46 while the NASDAQ rose 0.09% to 14,033.42. The S&P also rose, gaining 0.01% to 4,239.73. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
Curis Shares Drop After Updated CA-4948 Data From Mid-Stage Blood Cancer Trial ↗
Curis Inc (NASDAQ: CRIS) has announced updated data from its ongoing Phase 1/2 study of CA-4948 in patients with acute myeloid leukemia (AML) or high-risk... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers GBS (NASDAQ:GBS) stock increased by 41.04% to $5.12 during Friday's pre-market session. Novan (NASDAQ:NOVN) stock increased by 36.5% to $12.34. The company... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,... 
Via Benzinga
News headline image
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck ↗
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,... 
Via Benzinga
News headline image
Why Curis Stock Crashed on Thursday ↗
The swoon came shortly after some very good news for the company. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers MultiPlan (NYSE:MPLN) stock increased by 17.31% to $7.21 during Thursday's regular session. Trading volume for MultiPlan's stock is 4.0 million as of 12:30... 
Via Benzinga
News headline image
77 Biggest Movers From Yesterday ↗
Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) shares surged 23.7% to close at $12.77. Moxian, Inc. (NASDAQ: MOXC) jumped 23.6% to close at $9.52. Repro Med Systems, Inc... 
Via Benzinga
News headline image
44 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Reliance Global Group, Inc. (NASDAQ: RELI) jumped 38.7% to $4.0901 after the company said it has acquired a premier health insurance agency, J.P. Kush and Associates, Inc... 
Via Benzinga
News headline image
Curis Stock Is On A Wild Ride — What Spooked Investors After A 65% Surge ↗
Curis is taking investors on a wild ride. After rocketing on a promising blood-cancer drug on Wednesday, CRIS stock plummeted Thursday. 
Via Investor's Business Daily
News headline image
Curis Shares Drop On Safety Issues From Leukemia Study With CA-4948; Q1 Earnings Missing Estimates ↗
Curis Inc (NASDAQ: CRIS) stock gained momentum yesterday in reaction to updated data from its Phase 1/2 study of CA-4948 in patients with acute myeloid... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Palisade Bio (NASDAQ:PALI) shares moved upwards by 35.23% to $7.1 during Thursday's pre-market session. Lianluo Smart (NASDAQ:LLIT) shares rose 19.37% to $7.21... 
Via Benzinga
News headline image
26 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers Fuel Tech, Inc. (NASDAQ: FTEK) shares rose 26.3% to $2.45 in pre-market trading after the company reported upbeat results for its first quarter on Wednesday. Celyad... 
Via Benzinga
News headline image
Curis (CRIS) Q1 2021 Earnings Call Transcript ↗
CRIS earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
10 Stocks Moving In Wednesday's After-Hours Session ↗
Gainers GrowGeneration (NASDAQ: GRWG) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results and raised guidance. Sonos (NASDAQ: SONO)... 
Via Benzinga
News headline image
62 Biggest Movers From Yesterday ↗
Gainers Curis, Inc. (NASDAQ: CRIS) shares surged 65.5% to settle at $16.27 on Wednesday in reaction to updated data from its ongoing open-label, single-arm, Phase 1/2 study of CA... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Celyad Oncology (NASDAQ:CYAD) sto... 
Via Benzinga
News headline image
Why Curis (CRIS) Shares Are Surging Today? ↗
Curis Inc (NASDAQ: CRIS) shares are surging in reaction to updated data from its ongoing open-label, single-arm, Phase 1/2 study of CA-4948 in patients with... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers Curis (NASDAQ:CRIS) shares moved upwards by 57.23% to $15.46 during Wednesday's regular session. Trading volume for Curis's stock is 28.8 million as of 12:... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Titan Medical (NASDAQ:TMDI) shares rose 26.81% to $2.27 during Wednesday's pre-market session. The market value of their outstanding shares is at $248.6... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
News headline image
Earnings Scheduled For May 12, 2021 ↗
Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report... 
Via Benzinga
News headline image
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story